Tandem Diabetes Care
TNDM
309 hedge funds and large institutions have $5.59B invested in Tandem Diabetes Care in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 111 increasing their positions, 104 reducing their positions, and 59 closing their positions.
94% more call options, than puts
Call options by funds: $121M | Put options by funds: $62.6M
4.33% more ownership
Funds ownership: 89.68% → 94.01% (+4.3%)
7% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 104
4% less funds holding
Funds holding: 321 → 309 (-12)
9% less capital invested
Capital invested by funds: $6.16B → $5.59B (-$565M)
14% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 59
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$328M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$156M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$67.9M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$51.8M |
| 5 |
Morgan Stanley
New York
|
+$40.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$141M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$44.4M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$42M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$39.1M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$36.2M |
TNDM Hedge Fund Activity: Q4 2020 in Review
309 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q4 2020, worth a combined $5.59B — down 9.2% from $6.16B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of TNDM and 51 opened new positions — a net loss of 8 holders — while 104 trimmed existing stakes and 111 added.
The largest buyer was Jackson Square Partners, opening a new position worth an estimated $328M. The largest seller was Wellington Management Group, cutting an estimated $141M.
- 309 institutional investors held Tandem Diabetes Care (TNDM) as of Q4 2020, down from 321 in Q3 2020.
- Funds reported $5.59B of Tandem Diabetes Care stock for Q4 2020, down 9.2% quarter-over-quarter.
- 51 funds opened new Tandem Diabetes Care positions in Q4 2020 and 59 closed out, a net change of -8 holders.
- The largest Tandem Diabetes Care buyer in Q4 2020 was Jackson Square Partners, an estimated $328M added.
- The largest Tandem Diabetes Care seller in Q4 2020 was Wellington Management Group, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2020.